Furthermore, the size and number of the pancreatic tumor spheres were significantly reduced after anti-IL-17RB (D9) treatment, indicating that targeting-IL-17RB could inhibit cancer stemness activity (Fig. 4D). The gene discussed is IL17RB; the disease is cancer.